Antibodies.com

Cambridge, United Kingdom Founded: 2015 • Age: 11 yrs
Provider of portfolio of diagnostic reagents

About Antibodies.com

Antibodies.com is a Healthcare company based in Cambridge (United Kingdom) founded in 2015 by Stewart Newlove. Provider of portfolio of diagnostic reagents. Antibodies.com has raised $506.35 thousand across 1 funding round from investors including Nidobirds. The company has 3 employees. Its website antibodies.com draws about 90 thousand monthly visits. Antibodies.com offers products and services including Primary Antibodies, Secondary Antibodies, Proteins & Peptides, and ELISA Kits. Its focus areas include Life Sciences, Life Sciences Platforms and Tools, Research Reagents and Kits and Proteomics. Its legal entity is ANTIBODIES.COM LIMITED.

Company details

Antibodies.com was founded in 2015 and is located in Cambridge, United Kingdom, operating in the biotechnology sector focused on diagnostics. A variety of reagents is developed, encompassing primary and secondary antibodies, proteins like TNF-alpha Human and IL-4 Human, peptides, and immunoassay kits such as ELISA tests tailored to different samples. Searches can be filtered by clonality, reactivity, and applications to support research and diagnostic needs.

  • Headquarters Cambridge, United Kingdom
  • Employees 3
  • Founders Stewart Newlove
  • Sectors
    Healthcare
  • Email
    β€’β€’β€’β€’β€’β€’β€’β€’
  • Phone
    β€’β€’β€’β€’ β€’β€’β€’β€’
  • Website antibodies.com
  • Social LinkedIn X Facebook
  • Legal Name Antibodies.Com Limited
  • Date of Incorporation 27 Apr, 2015
  • Jurisdiction CAMBRIDGE, ENGLAND
Key Metrics
  • Total Equity Funding
    $506.35K (USD)

    in 1 rounds

  • Latest Funding Round
    $506.35K (USD), Seed

    Jul 2019

  • Investors
  • Employee Count
    3

Products & Services of Antibodies.com

Antibodies.com offers a comprehensive portfolio of products and services, including Primary Antibodies, Secondary Antibodies, Proteins & Peptides, and ELISA Kits.

Primary Antibodies
Research Tools

Antibodies for detecting specific proteins in research experiments.

Secondary Antibodies
Research Tools

Antibodies that enhance detection in immunoassays and blots.

Proteins & Peptides
Biochemicals

Purified proteins and peptides for biological studies.

ELISA Kits
Diagnostic Kits

Kits for measuring proteins via enzyme-linked assays.

Funding Insights of Antibodies.com

Antibodies.com has successfully raised a total of $506.35K through 1 strategic funding round. The most recent funding activity was a Seed round of $506.35 thousand completed in July 2019. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.

  • Total Funding $506,348
  • Total Rounds 1
  • Last Round Seed β€” $506,348
  • First Round $506,348

    (Jul 2019)

  • Investors Count 1

All 1 funding rounds of Antibodies.com with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.

DateAmountTransaction NameValuationLead InvestorsInvestors
Jul 2019$506,348Seed–Nidobirds Venture
–
Valuation history

1 investors in total: 1 institutional.

Investors in Antibodies.com

Antibodies.com has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include Nidobirds.

All
Institutional
InvestorDescriptionFounded YearDomainLocation
A venture support network for startups is operated by Nidobirds.
nidobirds.comHamburg, Germany
Premium access

Investor details for Antibodies.com

The complete investor list, round-by-round participation and investor portfolios require an active premium plan.

  • Complete investor list
  • Round participation
  • Investor portfolios
  • Co-investor network

Verified entity values are shown only after access is granted.

People of Antibodies.com

1 people are tracked at Antibodies.com (1 in leadership); the tracked headcount is 3.

NameRoleGroup
Stewart Newlove
FounderLeadership
Premium access

Complete people profiles for Antibodies.com

Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.

  • Full employee list
  • Team structure
  • Board tenure
  • Professional contacts

Verified entity values are shown only after access is granted.

Timeline of Antibodies.com

2 dated milestones of Antibodies.com across 4 years, from founding to its latest funding, stage changes and deals.

  1. Founded Antibodies.com is founded.
  2. Funding First funding round of $506K.

Web traffic of Antibodies.com

The website of Antibodies.com (antibodies.com) receives about 90K visits a month.

  • Monthly visits
    90K

    ▲ 35.4% vs previous month

Similar websites

Websites whose visitors overlap most with Antibodies.com. Affinity shows how closely the audiences match.

WebsiteDomainAudience affinityMonthly visitsGlobal rankProfile
affbiotech.com
affbiotech.com
100%
#1,549,129–
antibodies-online.com
99%
57.4K#648,443View details
antibodyregistry.org
98%
#1,236,479View details
absoluteantibody.com
98%
34.2K#944,741View details
creative-diagnostics.com
creative-diagnostics.com
95%
#298,431–
β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’.comβ€’β€’%β€’.β€’M#‒‒‒‒‒–
β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’.comβ€’β€’%β€’.β€’M#‒‒‒‒‒–
β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’.comβ€’β€’%β€’.β€’M#‒‒‒‒‒–
Premium access

All 40 similar websites and full traffic analytics for Antibodies.com

The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.

  • 40 similar websites
  • Audience overlap
  • Engagement analytics
  • Traffic by brand

Verified entity values are shown only after access is granted.

Top companies in Life Sciences Platforms & Tools

3 companies that operate in the same segment as Antibodies.com (Life Sciences Platforms & Tools) in United Kingdom, ranked by their profile score on The Company Check.

CompanyDescriptionFoundedLocationTotal fundingRevenueEmployees
Nanopore-based electronic systems for single-molecule analysis are developed.
2005Oxford, Oxfordshire, United KingdomUSD 1.34 BUSD 301.49 M1,372
Genetically modified cell lines are developed using AAV gene-editing platform.
2007Cambridge, Cambridgeshire, United KingdomUSD 46.29 M
Biological reagents and antibodies are developed for life science research.
1998Cambridge, Cambridgeshire, United KingdomUSD 78.8 M
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Related news about Antibodies.Com

Premium access

Complete news archive for Antibodies.com

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Antibodies.com

Antibodies.com was founded in 2015 and raised its 1st funding round 4 years after it was founded.

Antibodies.com is headquartered in Cambridge, United Kingdom. It is registered at Cambridge, Cambridgeshire, United Kingdom.

Antibodies.com is a funded company, having raised a total of $506.35K across 1 funding round to date. The company's 1st funding round was a Seed of $506.35K, raised on Jul 2019.

Antibodies.com has 3 employees.

Antibodies.com was founded in 2015 and is located in Cambridge, United Kingdom, operating in the biotechnology sector focused on diagnostics. A variety of reagents is developed, encompassing primary and secondary antibodies, proteins like TNF-alpha Human and IL-4 Human, peptides, and immunoassay kits such as ELISA tests tailored to different samples. Searches can be filtered by clonality, reactivity, and applications to support research and diagnostic needs.

Antibodies.com offers Primary Antibodies, Secondary Antibodies, Proteins & Peptides, and ELISA Kits.

Antibodies.com has 1 investor. Key investors include Nidobirds.

Antibodies.com operates through Antibodies.Com Limited.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available